PD 0449: Physician and patient preferences for early-stage and adjuvant treatment of genitourinary cancer in Asia-Pacific

PD 0471: Modulating Immune Response in Radical Cystectomy: The Role of Pre-Operative Immunomodulatory Nutrition on IL-10, CD4+, CD8+, and Albumin Levels

PD 0420: Evaluating the Performance of Cxbladder Triage and Detect and Imaging for the Detection of Urothelial Cancer in Patients with Gross Hematuria: A Canterbury, New Zealand Audit

PD 0451: The Diagnostic Performance Of Cxbladder Triage Plus For The Identification And Priority Evaluation Of Veterans At Risk For Urothelial Carcinoma: The Drive Study

PD 0464: The LOngitudinal Bladder cancer Study for Tumour rEcurRence (LOBSTER) Study of Cxbladder Monitor and Monitor Plus for Recurrence of Urothelial Carcinoma in Low, Intermediate, and High-Risk Patients: Trial in Progress

PD 0515: The Australian Urologic risk Stratification of patientS wIth hEmaturia (AUSSIE) Study of Cxbladder Performance for the Detection of Urothelial Carcinoma in Patients with Hematuria: Trial in Progress

PD 0585: Enfortumab Vedotin Plus Pembrolizumab Versus Chemotherapy in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma: Updated Analysis of the Pan-Asian Subgroup from EV-302/KEYNOTE-A39

PD 0596: Impact of Immune Checkpoint Inhibitors as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis

PD 0677: Development of Nomogram predicting outcome following radical cystectomy for bladder cancer :Data of Siriraj hospital , Thailand

PD 0705: Long-term oncologic outcomes following laparoscopic radical nephroureterectomy: Contemporary analysis from a Japanese multicenter study